Page last updated: 2024-11-02

pioglitazone and Encephalomyopathies, Mitochondrial

pioglitazone has been researched along with Encephalomyopathies, Mitochondrial in 1 studies

Pioglitazone: A thiazolidinedione and PPAR GAMMA agonist that is used in the treatment of TYPE 2 DIABETES MELLITUS.
pioglitazone : A member of the class of thiazolidenediones that is 1,3-thiazolidine-2,4-dione substituted by a benzyl group at position 5 which in turn is substituted by a 2-(5-ethylpyridin-2-yl)ethoxy group at position 4 of the phenyl ring. It exhibits hypoglycemic activity.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Bénit, P1
Pelhaître, A1
Saunier, E1
Bortoli, S1
Coulibaly, A1
Rak, M1
Schiff, M1
Kroemer, G1
Zeviani, M1
Rustin, P1

Other Studies

1 other study available for pioglitazone and Encephalomyopathies, Mitochondrial

ArticleYear
Paradoxical Inhibition of Glycolysis by Pioglitazone Opposes the Mitochondriopathy Caused by AIF Deficiency.
    EBioMedicine, 2017, Volume: 17

    Topics: Animals; Apoptosis Inducing Factor; Cells, Cultured; Cerebellum; Female; Fibroblasts; Glyceraldehyde

2017